more

Addus HomeCare (ADUS)

(Delayed Data from NSDQ)

$126.27 USD

+1.85 (1.49%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $126.18 -0.09 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

Top 12% (29 out of 250)

Industry: Medical - Outpatient and Home Healthcare

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

ADUS or USPH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on April 25,2019

ADUS vs. USPH: Which Stock Is the Better Value Option?

Quest Diagnostics (DGX) Jumps: Stock Rises 9.3%

by Zacks Equity Research Published on April 24,2019

Quest Diagnostics (DGX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

medical

Here's Why You Should Bet on Cooper Companies (COO) Stock Now

by Zacks Equity Research Published on April 11,2019

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across its segments and prudent acquisitions.

medical

Here's Why You Should Hold on to DaVita (DVA) Stock Now

by Zacks Equity Research Published on April 10,2019

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.

medical

ADUS vs. USPH: Which Stock Is the Better Value Option?

by Zacks Equity Research Published on April 08,2019

ADUS vs. USPH: Which Stock Is the Better Value Option?